AndroGel Co-Defendant Besins Gets Summary Judgment In Testosterone MDL

(May 31, 2018, 12:40 PM EDT) -- CHICAGO —  The Illinois federal judge overseeing the testosterone multidistrict litigation on May 29 granted summary judgment to AndroGel developer and co-defendant Besins Healthcare Inc. and a related entity because the plaintiffs either conceded the remaining liability theories or failed to provide evidence beyond citing a previous court order on Besins (In Re:  Testosterone Replacement Therapy Products Liability Litigation, Docket No. 2545, No. 14-1748, N.D. Ill, E. Div., 2018 U.S. Dist. LEXIS 88862)....

Attached Documents

Related Sections